Minovia Therapeutics
Israel - Tirat HacarmelBiotechnology
Focus: Minovia Therapeutics is an early-stage Israeli biotech focused on cell therapy for mitochondrial diseases, leveraging enriched CD34+ cells and bone marrow mobilization approaches. The company is pre-revenue with a nascent pipeline in Phase 1/2 development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Minovia Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Minovia Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mito
Pregnancy RelatedClinical Trials (1)
NCT03762512Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies
N/AHelp build intelligence for Minovia Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.